Analyst firms · Raymond James · MDT

Raymond James MDT price target and rating history

Medtronic plc. (MDT) · Health Care

Raymond James rates Medtronic plc. (MDT) Mkt Perform with a $116 price target, as of its latest action on Aug 24, 2022. It has published 3 rating actions on MDT since August 2021, including 0 upgrades and 1 downgrade. Across 8 firms with a MDT price target in the last 12 months, the median target is $107.

Current rating
Mkt Perform
Price target
$116
Median target, all firms
$107
Actions on MDT
3

Raymond James price target on MDT

$142$129$11620222023202420252026
Raymond James price target on MDT, each point a stated target, August 2021 to February 2022.

Every Raymond James rating on MDT

How other firms rate MDT

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Piper SandlerOverweight$120Nov 17, 2026
BarclaysEqual Weight$95Oct 7, 2026
NeedhamBuy$114Aug 27, 2026
UBSBuy$100Jul 28, 2026
BTIGBuy$90Jun 4, 2026
Goldman SachsNeutral$84May 21, 2026
CitigroupBuy$117Feb 3, 2026
Wells FargoOverweight$114Jan 30, 2026
William BlairOutperformJan 6, 2026

Questions about Raymond James and MDT

What is Raymond James's price target for MDT?
Raymond James's latest stated price target for Medtronic plc. (MDT) is $116, from its action on Feb 18, 2022.
What is Raymond James's rating on MDT?
Raymond James rates MDT Mkt Perform, a neutral rating, as of Aug 24, 2022.
When did Raymond James last change its view on MDT?
On Aug 24, 2022, Raymond James downgrades to Mkt Perform from Outperform.
How does Raymond James's MDT target compare with other analysts?
Across 8 firms with a MDT price target in the last 12 months, the median target is $107.

More MDT rating histories

All Raymond James ratingsMDT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.